Zhou L, Li Y, Sweeney EM, Wang XH, Kuceyeski A, Chiang GC, Ivanidze J, Wang Y, Gauthier SA, de Leon MJ et al..
2023.
Association of brain tissue cerebrospinal fluid fraction with age in healthy cognitively normal adults.. Front Aging Neurosci. 15:1162001.
Zolin A, Zhang C, Ooi H, Sarva H, Kamel H, Parikh NS.
2023.
Association of liver fibrosis with cognitive decline in Parkinson's disease.. J Clin Neurosci. 119:10-16.
Williams MJ, Okai AF, Cross AH, Monson NL, Vartanian T, Thrower BW, Reder AT, English JB, Wu GF, Bernitsas E et al..
2023.
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial.. Mult Scler Relat Disord. 76:104794.
Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson KR, Kakara M, Zuroff L, Bennett JL, von Büdingen H-C, Carruthers R et al..
2023.
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.. Proc Natl Acad Sci U S A. 120(3):e2207291120.
Michaelson NMiriam, Watsula A, Bakare-Okpala A, Mohamadpour M, Chukwueke UN, Budhu JA.
2023.
Disparities in Neuro-Oncology.. Curr Neurol Neurosci Rep.
Homssi M, Sweeney EM, Demmon E, Mannheim W, Sakirsky M, Wang Y, Gauthier SA, Gupta A, Nguyen TD.
2023.
Evaluation of the Statistical Detection of Change Algorithm for Screening Patients with MS with New Lesion Activity on Longitudinal Brain MRI.. AJNR Am J Neuroradiol. 44(6):649-655.
Telesford KM, Smith C, Mettlen M, Davis MB, Cowell L, Kittles R, Vartanian T, Monson N.
2023.
Neuron-binding antibody responses are associated with Black ethnicity in multiple sclerosis during natalizumab treatment.. Brain Commun. 5(4):fcad218.